SEI Investments
IMNM icon

SEI Investments’s Immunome IMNM Stock Holding History

SEI Investments’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
62,483
+9,713
+18% +$208K ﹤0.01% 2158
2026
Q1 		$1.15M Buy
52,770
+25,051
+90% +$558K ﹤0.01% 2290
2025
Q4 		$595K Buy
+27,719
New +$486K ﹤0.01% 2429
2024
Q4 		– Sell
-14,918
Closed -$218K – 2754
2024
Q3 		$218K Buy
14,918
+2,380
+19% +$33.8K ﹤0.01% 2447
2024
Q2 		$152K Sell
12,538
-6,452
-34% -$101K ﹤0.01% 2492
2024
Q1 		$469K Buy
+18,990
New +$385K ﹤0.01% 2131

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

SEI Investments's IMNM Position: Q2 2026 in Review

SEI Investments increased its Immunome (IMNM) stake by 18% in Q2 2026, buying an estimated $208K and bringing the position to 62,483 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

SEI Investments first reported a position in IMNM in Q1 2024 and has held it in 6 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • SEI Investments held 62,483 shares of Immunome worth $1.32M as of Q2 2026.
  • SEI Investments bought 9,713 Immunome shares in Q2 2026, an estimated $208K.
  • Immunome made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2158 holding.
  • SEI Investments first reported a position in Immunome in Q1 2024 and has held it in 6 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.